Added to YB: 2019-08-22
Pitch date: 2019-08-22
ZIOP [bearish]
Alaunos Therapeutics, Inc.
+99.5%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive T-cell receptor (TCR) engineered T-cell therapies (TCR-T) to treat multiple solid tumor types.
Market Cap
$2.4M
Pitch Price
$844.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.26
P/E
-0.50
EV/Sales
126.28
Sector
Biotechnology
Category
N/A
Show full summary:
ZIOPHARM ONCOLOGY INC ZIOP
A summary for this pitch has not been created yet.
Read full article (0 min)